SCHEMBL22018818

SCHEMBL22018818

O=C(Nc1cnc2ccccc2c1C1CCCCCCCC1)C1CCCCCCC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MALT1 Q9UDY8 2/20 0.53
NPC1 O15118 2/20 0.52
RAB9A P51151 2/20 0.52
MAPT P10636 1/20 0.49
HTT P42858 1/20 0.49
CETP P11597 1/20 0.49
HDAC3 O15379 1/20 0.49
HDAC1 Q13547 1/20 0.49
HDAC2 Q92769 1/20 0.49
HPGD P15428 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
POLB P06746 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
LMNA P02545 1/20 0.44
PKM P14618 1/20 0.44
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
HSD17B10 Q99714 1/20 0.43
ADORA2A P29274 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19059691 1.00 MALT1 (0.53) MALT1NPC1RAB9AMAPTHTT
SCHEMBL21157256 1.00 MALT1 (0.53) MALT1NPC1RAB9AMAPTHTT
SCHEMBL18399531 1.00 MALT1 (0.53) MALT1NPC1RAB9AMAPTHTT
SCHEMBL19059692 1.00 MALT1 (0.53) MALT1NPC1RAB9AMAPTHTT
SCHEMBL20368669 1.00 MALT1 (0.53) MALT1NPC1RAB9AMAPTHTT
SCHEMBL22138677 0.86 MALT1 (0.54) MALT1RAB9AMAPTHTTKDM4E
SCHEMBL18399529 0.84 MALT1 (0.52) MALT1KDM4E
SCHEMBL2708377 0.84 NPC1 (0.53) NPC1RAB9AMAPTHTTCETP
SCHEMBL20368668 0.81 HDAC3 (0.51) NPC1RAB9AMAPTHTTCETP
SCHEMBL21158406 0.80 BCHE (0.50) NPC1RAB9AMAPTHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10828290-B2 Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors INCYTE CORPORATION (US) 2020-11-10 US disclosed
US-20200155527-A1 THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS INCYTE HOLDINGS CORPORATION 2020-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200155527-A1 THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS PIM2, PIM1, PIM3 MALT1 1158/4885NPC1 2615/4885RAB9A 4447/4885
US-10828290-B2 Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors PIM2, PIM1, PIM3 MALT1 1158/4885NPC1 2615/4885RAB9A 4447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.